· The report will be published at 07:30 CET. · Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO and Håkan Bergström, CFO. To take part in the conference call, please dial in about five minutes in advance. · UK dial-in number: +44 (0) 203 008 98 01 · US dial-in number: +1 646 502 51 18 · Swedish dial-in number: +46 (0) 2 00 88 38 17 The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions it is necessary to call in): http://event.onlineseminarsolutions.com/r.htm?e=1304981&s=1&k=E3404F72CB10AABEE6D468FAD6E086E1 # # # For further information, please contact: Johan Andersson, Director Investor Relations, Elekta AB. Tel: +46 702 100 451, e-mail: firstname.lastname@example.org Time zone: CET: Central European Time Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: email@example.com Time zone: CET: Central European Time Frida Johansson, Investor Relations, Elekta AB Tel: +46 708 667 674, e-mail: firstname.lastname@example.org Time zone: CET: Central European Time About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,600 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.